You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
|
---|---|
Published in |
American Journal of Hematology, May 2019
|
DOI | 10.1002/ajh.25489 |
Pubmed ID | |
Authors |
Elisa Rumi, Silvia Zibellini, Emanuela Boveri, Chiara Cavalloni, Roberta Riboni, Ilaria Carola Casetti, Michele Ciboddo, Chiara Trotti, Cristina Favaron, Daniela Pietra, Chiara Candido, Virginia Valeria Ferretti, Mario Cazzola, Luca Arcaini |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 63% |
France | 1 | 13% |
Saudi Arabia | 1 | 13% |
Unknown | 1 | 13% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Scientists | 2 | 25% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 25% |
Researcher | 2 | 13% |
Student > Doctoral Student | 1 | 6% |
Student > Ph. D. Student | 1 | 6% |
Other | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 25% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Business, Management and Accounting | 1 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Agricultural and Biological Sciences | 1 | 6% |
Other | 1 | 6% |
Unknown | 7 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2020.
All research outputs
#6,942,504
of 24,220,739 outputs
Outputs from American Journal of Hematology
#1,182
of 3,529 outputs
Outputs of similar age
#123,737
of 354,584 outputs
Outputs of similar age from American Journal of Hematology
#26
of 52 outputs
Altmetric has tracked 24,220,739 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 3,529 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.